BioCryst Pharmaceuticals Inc. Common Stock (BCRX)
Stock · NASDAQ · Health Care
$9.82as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$8.97
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
How BioCryst Pharmaceuticals Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
BioCryst Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- BCRXBioCryst Pharmaceuticals Inc. Common Stock$9.82▼ 0.51%Market cap $2.24BP/E —
- COAGHemab Therapeutics Holdings Inc. Common Stock$44.77▼ 9.55%Market cap $2.10BP/E —$23$55.42
- KODKodiak Sciences Inc Common Stock$37.77▼ 3.45%Market cap $2.49BP/E —$8.29$47.84
- MESOMesoblast Limited American Depositary Shares$17.42▼ 4.18%Market cap $1.87BP/E —$1.88$3.31
- BEAMBeam Therapeutics Inc. Common Stock$29.31▼ 3.84%Market cap $2.67BP/E —$16.02$38.26
- RXRXRecursion Pharmaceuticals Inc. Class A Common Stock$3.33▼ 3.20%Market cap $1.69BP/E —$2.77$7.18
- GLUEMonte Rosa Therapeutics Inc. Common Stock$13.37▼ 6.63%Market cap $1.30BP/E —$4.6$25.77
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals Inc. Common Stock | $2.24B | — | $9.82 | ▼ 0.51% | |
| COAG Hemab Therapeutics Holdings Inc. Common Stock | $2.10B | — | $44.77 | ▼ 9.55% | $23$55.42 |
| KOD Kodiak Sciences Inc Common Stock | $2.49B | — | $37.77 | ▼ 3.45% | $8.29$47.84 |
| MESO Mesoblast Limited American Depositary Shares | $1.87B | — | $17.42 | ▼ 4.18% | $1.88$3.31 |
| BEAM Beam Therapeutics Inc. Common Stock | $2.67B | — | $29.31 | ▼ 3.84% | $16.02$38.26 |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | $1.69B | — | $3.33 | ▼ 3.20% | $2.77$7.18 |
| GLUE Monte Rosa Therapeutics Inc. Common Stock | $1.30B | — | $13.37 | ▼ 6.63% | $4.6$25.77 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 232.86M
- Total value held
- $2.18B
- Institutional holders
- 291
Top holders this quarter
- Unknown22.65M
- Unknown15.83M
- Unknown15.04M
- Unknown12.21M
- Unknown11.14M
- Unknown11.02M
- Unknown8.91M
- Unknown7.43M
- Unknown7.03M
- Unknown6.39M
See the full, filterable feed with live charts on the MarketWall dashboard.